Bath & Body Works, Inc

Bath & Body Works, Inc (NYSE: BBWI) is a worldwide omnichannel retailer specializing in personal care and home fragrance products. The company provides a diverse selection of body and home scents, featuring collections that include 3-wick candles, home fragrance diffusers, fine fragrance mists, liquid hand soaps, body lotions, and body creams.

Key Financial Updates:

• Solid Financial Performance in Q1 2025: Bath & Body Works reported robust financial results for the first quarter of fiscal year 2025, with net sales reaching USD 1.4 billion, marking a 2.9% increase compared to the prior year. The company achieved the high end of its sales guidance and delivered diluted earnings per share of USD 0.49, exceeding expectations. This performance represents the strongest quarter of underlying sales growth since 2021, driven by positive traffic across both store and direct channels. Notably, growth was recorded in all three core categories: Body Care, Home Fragrance, and Soaps & Sanitizers.
• Category and Channel Highlights: During the quarter, Bath & Body Works witnessed balanced growth across its product categories. The Body Care and Home Fragrance segments each posted low single-digit sales increases, while Soaps & Sanitizers experienced mid-single-digit growth, supported by successful product innovations such as sanitizer sprays, single wick candles, and wallflowers. The company’s store sales, representing 78% of net sales, grew by 4.3%, benefiting from the expansion of the Buy Online, Pickup In Store (BOPIS) offering. Meanwhile, direct sales accounted for 17% of net sales, while international operations contributed 5%, with system-wide retail sales rising by approximately 10%.
• Operational Excellence and Efficiency Initiatives: The company continued to enhance its operational capabilities by leveraging its Ohio-based Beauty Park and U.S.-centric supply chain, which facilitated speed, agility, and cost efficiency. Bath & Body Works also advanced its cost discipline efforts, proactively addressing tariff exposures and implementing strategies to mitigate the effects of global trade policy shifts. Furthermore, the company maintained disciplined capital allocation, including planned share repurchases of approximately USD 300 million and capital expenditures of USD 250 million to USD 270 million for the fiscal year.
• Customer-Centric Innovation and Experience: Bath & Body Works focused on deepening its customer connection through product innovation and an enhanced shopping experience. The success of collaborations such as the Disney line and seasonal collections around key holidays fueled consumer excitement. The company also introduced in-store innovations, including interactive fragrance bars and open layouts, while continuing to refine its loyalty program. By the end of Q1 2025, the loyalty program had approximately 39 million active members, accounting for over 80% of U.S. sales, reflecting strong customer engagement.
• Strategic Growth in Adjacencies and International Markets: The company remains committed to expanding in adjacent categories such as Men’s, Lip, Hair, and Laundry, which together represent about 10% of total sales. Bath & Body Works views these categories as opportunities to broaden its customer base and apply its fragrance expertise to new markets. International expansion also continues to be a long-term strategic priority, with store openings in key regions contributing to the company’s global presence and growth prospects.
• Fiscal 2025 Outlook and Guidance: Looking ahead, Bath & Body Works reaffirmed its full-year guidance, projecting net sales growth between 1% and 3% and earnings per diluted share ranging from USD 3.25 to USD 3.60. The company expects to sustain a gross profit rate of approximately 44% while managing SG&A expenses at around 27.5% of net sales. Investments in marketing and technology will continue to support growth, while cost savings initiatives and share repurchases are expected to drive shareholder value. The company remains confident in its ability to navigate external challenges and deliver on its strategic objectives for fiscal 2025.

Technical Observation (on the daily chart):

BBWI is declining with the stock trading below its 21-day and 50-day moving averages, which are both sloping downward. The recent price of around USD 25.21 has broken prior support levels, and the RSI near 28 indicates the stock is in oversold territory, suggesting the possibility of a short-term bounce.

Bath & Body Works delivered a strong start to fiscal 2025, achieving net sales at the high end of guidance and surpassing earnings expectations with a 28.9% year-over-year increase in diluted EPS. The company demonstrated resilience and momentum with its strongest underlying sales growth since 2021, driven by innovation, successful collaborations, and robust performance across all core categories. With disciplined operational execution, a growing loyalty base, and ongoing investments in customer experience, Bath & Body Works is well-positioned to accelerate growth, strengthen its market leadership, and create lasting value for shareholders.

As per the above-mentioned price action, recent key business and financial updates, momentum in the stock over the last month, and technical indicators analysis, a ‘Buy’ rating has been given to Bath & Body Works, Inc (NYSE: BBWI) at the closing market price of USD 25.21 as of June 13,2025. 

Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario. 

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Related Risk: This report may be looked at from a high-risk perspective and a recommendation is provided for a short duration. This report is solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc. 

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is June 13,2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.